Long term survivors of childhood cancer: Cure and care. The ERICE statement.
Authors:
T. Kepák 1; J. Radvanská 2; V. Bajčiová 1; M. Blatný 3; H. Hrstková 4; J. Kuře 5; V. Mihál 6; J. Starý 2; V. Šmelhaus 2; J. Štěrba 1; J. Koutecký 2; Pediatricko Onkologická Sekce České Onkologické Společnosti
Authors‘ workplace:
Klinika dětské onkologie LF MU a FN Brno 2Klinika dětské hematologie a onkologie 2. LF UK a FN Motol, Praha 3Psychologický ústav Akademie věd České republiky, Praha 4I. dětská interní a onkologická klinika LF MU a FN Brno 5Ústav lékařské etiky LF MU, Brno
1
Published in:
Klin Onkol 2009; 22(2): 77-79
Category:
Oncology Highlights
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2009 Issue 2
Most read in this issue
- The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells
- Trastuzumab in the breast cancer treatment: efficacy and resistance mechanisms
- Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults
- Bevacizumab in combination with capecitabine and irinotecan (XELIRi) in treatment of metastatic colorectal cancer